NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-194-2015-0-PCT-02 Imaging Systems And Methods Using Floursecent Nanodiamonds PCT PCT PCT/US16/026791 Expired
NHLBI E-194-2015-0-AU-05 Imaging Systems And Methods Using Floursecent Nanodiamonds AU National Stage 2016246057 Abandoned
NHGRI E-185-2014-0-ES-08 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder ES EP 16717228.7 Issued
NHGRI E-185-2014-0-EP-06 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder EP National Stage 16717228.7 Issued
NHGRI E-185-2014-0-IT-11 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder IT EP 16717228.7 Issued
NHGRI E-185-2014-0-DE-07 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder DE EP 16717228.7 Issued
NHGRI E-185-2014-0-FR-09 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder FR EP 16717228.7 Issued
NHGRI E-185-2014-0-GB-10 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder GB EP 16717228.7 Issued
NCI E-001-2014-0-US-03 Antibodies That Specifically Bind Ataxia Telangiectasia-Mutated and RAD3-Related Kinase Phosphorylated at Positions 1989 and Their Use US National Stage 15/027,997 9644037 Issued PDF
NHGRI E-185-2014-0-PCT-02 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder PCT PCT PCT/US2016/026524 Expired
NHGRI E-185-2014-0-US-04 VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER US National Stage 15/565,065 Abandoned
NHGRI E-185-2014-0-CA-05 Viral Gene Therapy As Treatment For Cholesterol Storage Disease or Disorder CA National Stage 2982129 Pending
CC E-028-2017-0-US-02 DEVICES WITH LOW MELTING POINT ALLOY FOR CONTROL OF DEVICE FLEXIBILITY US ORD 15/091,822 10688656 Issued PDF
NIDCR E-736-2013-1-US-02 Detection of Hepatitis Delta Virus (HDV) For the Diagnosis and Treatment of Sjogren's Syndrome and Lymphoma US National Stage 15/027,546 10584387 Issued PDF
NCI E-771-2013-4-JP-14 Modified Pseudomonas Exotoxin A JP National Stage 2016-520651 Abandoned
NIDCR E-097-2015-0-US-02 Adeno-Associated Vectors for Enhanced Transduction and Reduced Immunogenicity US ORD 15/092,482 10081659 Issued PDF
NCI E-115-2015-0-PCT-02 Hypoxia Inducible Factor 1 (HIF-1) Inhibitors PCT PCT PCT/US2016/026145 Expired
NCI E-255-2015-1-JP-01 Selective Propagation, Maintenance, And Induction Of Nephron Stem Cells JP ORD 2016-076839 Pending
NCI E-130-2011-0-US-12 Human Monoclonal Antibodies Specific for Glypican-3 and Use Thereof US CON 15/090,873 9932406 Issued PDF
NCI E-025-2009-0-AU-24 Ratio Based Biomarkers And Methods of Use Thereof AU DIV 2016202107 Issued
NCI E-025-2011-2-US-04 Antibodies To Tumor Endothelial Marker 8 US DIV 15/090,058 10273299 Issued PDF
NCI E-153-2009-0-US-16 Agents and Methods to Elicit Anti-Tumor Immune Response US DIV 15/089,016 9951311 Issued PDF
NINDS E-023-2014-0-US-14 Insulin-Like Growth Factor Mimetics For Use In Therapy US National Stage 15/026,792 Abandoned
NHLBI E-342-2013-0-US-03 Human IPSC-Derived Vascular-Related And Hematopoetic Cells For Therapies And Toxicology/Drug Screenings US National Stage 15/026,313 10385313 Issued PDF
NCI E-508-2013-2-CN-05 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE CN National Stage 201480054322.2 Issued
NCI E-771-2013-4-GB-18 Modified Pseudomonas Exotoxin A GB EP 14789449.7 Issued
NCI E-771-2013-4-FR-17 Modified Pseudomonas Exotoxin A FR EP 14789449.7 Issued
NCI E-771-2013-4-DE-16 Modified Pseudomonas Exotoxin A DE EP 14789449.7 Issued
NCI E-239-2009-0-US-04 DNA-PROTEIN VACCINATION PROTOCOLS US CON 15/085,903 Abandoned
NHGRI E-044-2013-0-US-06 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) US CON 15/084,255 9833468 Issued PDF
NHLBI E-759-2013-0-US-04 Vascular Dilators US National Stage 15/025,336 10537718 Issued PDF
NCI E-010-2008-0-US-04 Methods and Compositions for Protein Delivery US DIV 15/082,401 1004-08-30 Issued PDF
NCI E-025-2015-0-PCT-02 ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND METHODS PCT PCT PCT/US2016/024531 Expired
NIAID E-248-2006-0-CN-20 "Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus" CN DIV 201610183481.3 Pending
NIDDK E-067-2010-0-JP-10 Inverse Agonists And Neutral Antagonists For the TSH Receptor JP DIV 2016-59757
NCATS E-088-2016-0-FR-07 Inhibitors Of 12/15-Lipoxygenase FR EP 14837235.2 Issued
NCATS E-088-2016-0-DE-06 Inhibitors Of 12/15-Lipoxygenase DE EP 14837235.2 Issued
NCATS E-088-2016-0-EP-04 Inhibitors Of 12/15-Lipoxygenase EP National Stage 14837235.2 Issued
NCATS E-088-2016-0-GB-08 Inhibitors Of 12/15-Lipoxygenase GB EP 14837235.2 Issued
NCATS E-088-2016-0-CH-05 Inhibitors Of 12/15-Lipoxygenase CH EP 14837235.2 Issued
NCATS E-326-2008-0-US-11 Activators Of Human Pyruvate Kinase US CON 15/076,258 9707230 Issued PDF
NIAID E-219-2016-0-EP-03 Serum Antibody Assay For Determining Protection From Malaria, And Pre-Erythrocytic Subunit Vaccines EP National Stage 14839238.4 Abandoned
NIAID E-131-2015-2-ZA-08 Neutralizing Antibodies to GP120 and Their Use ZA National Stage 2017/06155 Issued
NIAID E-131-2015-2-CN-04 Neutralizing Antibodies to GP120 and Their Use CN National Stage 201680028822.8 Issued
NIAID E-131-2015-2-IN-06 Neutralizing Antibodies to GP120 and Their Use IN National Stage 201737032671 Issued
NIAID E-131-2015-2-AU-02 Neutralizing Antibodies to GP120 and Their Use AU National Stage 2016235541 Issued
NIAID E-131-2015-2-BE-13 Neutralizing Antibodies to GP120 and Their Use BE EP 16716979.6 Issued
NIAID E-131-2015-2-AT-12 Neutralizing Antibodies to GP120 and Their Use AT EP 16716979.6 Issued
NIAID E-131-2015-2-AL-11 Neutralizing Antibodies to GP120 and Their Use AL EP 16716979.6 Issued
NIAID E-131-2015-2-BG-14 Neutralizing Antibodies to GP120 and Their Use BG EP 16716979.6 Issued